AUTHOR=Giani Teresa , De Masi Salvatore , Maccora Ilaria , Tirelli Francesca , Simonini Gabriele , Falconi Martina , Cimaz Rolando 

TITLE=The Influence of Overweight and Obesity on Treatment Response in Juvenile Idiopathic Arthritis

JOURNAL=Frontiers in Pharmacology

VOLUME=10

YEAR=2019

URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2019.00637

DOI=10.3389/fphar.2019.00637

ISSN=1663-9812

ABSTRACT=<p><bold>Background:</bold> There is evidence that obesity could be a risk factor for the severity and response to treatment in adult patients with rheumatoid arthritis (RA) due both to the mechanical effect of overweight and to the potential pro-inflammatory effects of cytokines produced by adipose tissue.</p><p><bold>Objectives:</bold> To evaluate the role of overweight and obesity in a cohort of young patients with juvenile idiopathic arthritis (JIA) in terms of incidence, disease activity, outcome, and response to treatments.</p><p><bold>Methods:</bold> This single-center retrospective cohort study evaluated 110 children affected by JIA under treatment with conventional disease-modifying antirheumatic drugs (DMARDs) and biologic agents. Body mass index (BMI) categories of 5–84th (normal weight), 85–94th (overweight), and ≥95th (obese) percentile were used. Patients with systemic JIA, uveitis, chronic comorbidities, or under other potentially confounding systemic treatments were excluded. Uni- and multivariate analyses were performed.</p><p><bold>Results:</bold> One hundred and ten JIA patients (polyarticular <italic>n</italic> = 50, oligoarticular <italic>n</italic> = 38, psoriatic <italic>n</italic> = 12, enthesitis-related arthritis <italic>n</italic> = 8, undifferentiated <italic>n</italic> = 2) were enrolled in the study, 75% girls and 25% boys. The mean age at treatment onset was 6.09 years. Baseline BMI was ≥5th and ≤84th percentile in 80 patients, 85–94th in 27, and ≥95th in 3.</p><p>We did not observe a significant association between BMI and erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), or number of active joints at baseline, while involvement of the joints of lower limbs was significantly greater ( <italic>p</italic> = 0.025) in overweight/obese patients. However, a trend toward lower remission rates and higher number of relapses, both after DMARDs and biologics, in patients with higher BMI was observed.</p><p><bold>Conclusion:</bold> This study focuses on the relationship between overweight/obesity and JIA. A significant correlation between obesity and a greater involvement of the joints of the lower limbs at baseline was demonstrated. Furthermore, our data suggest that obesity could negatively influence the course of the disease as well as treatment response.</p>